O

Omeros Corporation

223 employees

Omeros is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Pharmaceutical

Date founded

1994

Funding rounds raised

Total raised

$125M

from 4 investors over 4 rounds

O

Omeros Corporation raised $6.7M on April 10, 2023

Investors: The National Institute on Drug Abuse (NIDA)

O

Omeros Corporation raised $125M on November 4, 2016

Investors: CRG LP

O

Omeros Corporation raised $20M on May 17, 2016

Investors: Oxford Finance LLC

O

Omeros Corporation raised $70M on January 6, 2016

Investors: Oxford Finance LLC

FAQ